Recommendations,Strength rating
Recommendations,Strength rating
"2022 recommendation: Use diagnostic ureteroscopy and biopsy if imaging and 
cytology are not sufficient for the diagnosis and/or risk-stratification of the tumour.",Strong
"Revised 2023 recommendation: Use diagnostic ureteroscopy (preferably without 
biopsy) if imaging and/or voided urine cytology are not sufficient for the diagnosis 
and/or risk-stratification of patients suspected to have UTUC.",Strong
"2022 recommendation: Magnetic resonance urography or 18F-Fluorodeoxglucose 
positron emission tomography/CT may be used when CT is contra-indicated.",Weak
"Revised 2023 recommendation: Magnetic resonance urography or 
18F-Fluorodeoxglucose positron emission tomography/CT (to assess [nodal] 
metastasis) may be used when CT is contra-indicated.",Weak
